Encorafenib — a new agent for advanced-stage disease
Encorafenib — a new agent for advanced-stage diseaseEncorafenib — a new agent for advanced-stage disease, Published online: 12 April 2018; doi:10.1038/s41571-018-0019-xEncorafenib — a new agent for advanced-stage disease
Source: Nature Clinical Practice Oncology - Category: Cancer & Oncology Authors: Peter Sidaway Source Type: research
More News: Cancer & Oncology